Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18936107 | 0.80 | CYP1A2 (0.36) | ATM | |
| SCHEMBL728135 | 0.79 | MTNR1A (0.34) | TYMSKDM4EMAPK1ATM | |
| SCHEMBL18936189 | 0.75 | ACHE (0.33) | — | |
| SCHEMBL18936082 | 0.75 | HPGD (0.38) | KDM4EATM | |
| SCHEMBL18936150 | 0.75 | AHR (0.50) | — | |
| SCHEMBL18936162 | 0.70 | SCN9A (0.32) | KDM4E | |
| SCHEMBL18936074 | 0.70 | BRD4 (0.33) | — | |
| SCHEMBL3557 | 0.70 | — | — | |
| SCHEMBL30493572 | 0.69 | AHR (0.48) | TYMSKDM4EMAPK1ATM | |
| SCHEMBL18936173 | 0.69 | ALDH1A1 (0.44) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10294193-B2 | Compound, and flavor composition and/or fragrance composition containing same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-05-21 | — | — | US | disclosed |
| EP-3153492-A1 | NOVEL COMPOUND AND FRAGRANCE COMPOSITION CONTAINING SAME | Takasago International Corporation (JP) | 2017-04-12 | — | — | EP | disclosed |
| US-20170088503-A1 | NOVEL COMPOUND, AND FLAVOR COMPOSITION AND/OR FRAGRANCE COMPOSITION CONTAINING SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
| EP-2377841-A1 | METHOD FOR PRODUCING ALCOHOL COMPOUND | Takasago International Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10294193-B2 | Compound, and flavor composition and/or fragrance composition containing same | FZD7, TAS1R1, TAS2R5 | TYMS 3822/4885KDM4E 1885/4885MAPK1 885/4885 |
| US-20170088503-A1 | NOVEL COMPOUND, AND FLAVOR COMPOSITION AND/OR FRAGRANCE COMPOSITION CONTAINING SAME | FZD7, TAS2R5, TAS2R40 | TYMS 3921/4885KDM4E 1578/4885MAPK1 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.